On the same day that he became the presumptive Democratic nominee for President, Sen. Barack Obama introduced new legislation to expand public access to information about government spending.
The bill (pdf), known as “The Strengthening Transparency and Accountability in Federal Spending Act of 2008,” was crafted on a bi-partisan basis with Sen. Tom Coburn (R-OK).
Sen. John McCain, the Republican presidential candidate, is also an original co-sponsor of the bill, as is Sen. Tom Carper (D-DE).
The new bill would build upon and improve previous efforts by Senators Obama and Coburn to provide public access to federal grant and contract information through the USASpending.gov web site. Among other things, it would require copies of each federal contract and details of the bidding process to be published online.
The provisions of the bill were outlined in a joint press release on June 3.
“People from every State in this great Nation sent us to Congress to defend their rights and stand up for their interests,” Sen. Obama said in a prepared floor statement. “To do that we have to tear down the barriers that separate citizens from the democratic process and to shine a brighter light on the inner workings of Washington. This bill helps to shine that light.”
While most government agencies have cooperated with the contracting transparency requirements that were adopted in 2006, some intelligence agencies have dragged their heels in opposition. The Defense Intelligence Agency and the National Geospatial-Intelligence Agency, which used to disclose their unclassified contracts, actually withheld such information from the USASpending.gov database in 2007 and 2008.
Given the rapid pace of AI advancement, a proactive effort triumphs over a reactive one. To protect consumers, workers, and the economy more broadly, it is imperative that the FTC and DOJ adapt their enforcement strategies to meet the complexities of the AI era.
To encourage greater adoption of generic drugs in clinical practice the FDA should implement a dedicated regulatory pathway for non-manufacturers to seek approval of new indications for repurposed generic drugs.
The increasing frequency of extreme weather events, which caused over $200 billion in global economic losses in 2023, is disrupting global supply chains and exacerbating migration pressures, particularly for the U.S. Investing in climate resilience abroad offers a significant opportunity for U.S. businesses in technology, engineering, and infrastructure, while also supporting job creation at home.
Early-career and out-of-state teachers tend to be most heavily concentrated in Alaska’s rural schools, where they face a steep curve in adjusting to a new way of life while learning the ropes of teaching.